We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$6.69M
AG
2
Artal Group
Luxembourg
$4.65M
APM
3
Avidity Partners Management
Texas
$4.61M +$1.8M +559,404 +62%
FP
4
Flagship Pioneering
Massachusetts
$3.13M
SB
5
Samsara BioCapital
California
$2.78M
CA
6
CHI Advisors
New York
$2.42M
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$2.27M
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.57M +$32.1K +9,986 +2%
DCM
9
DAFNA Capital Management
California
$838K
OFM
10
Omega Fund Management
Massachusetts
$792K
BlackRock
11
BlackRock
New York
$665K +$73.6K +22,910 +12%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$409K +$150K +46,784 +56%
ECM
13
ExodusPoint Capital Management
New York
$373K -$10.1K -3,157 -3%
Goldman Sachs
14
Goldman Sachs
New York
$332K +$608 +189 +0.2%
DMKJ
15
David M. Knott Jr
$303K +$309K +96,260 New
LPL Financial
16
LPL Financial
California
$296K +$35K +10,886 +13%
LCP
17
LGT Capital Partners
Switzerland
$173K
Renaissance Technologies
18
Renaissance Technologies
New York
$145K +$964 +300 +0.7%
BCM
19
Bridgeway Capital Management
Texas
$124K -$32.1K -10,000 -20%
State Street
20
State Street
Massachusetts
$104K
GCP
21
GSA Capital Partners
United Kingdom
$86K +$34.1K +10,613 +63%
Corient Private Wealth
22
Corient Private Wealth
Florida
$84K
SC
23
Shay Capital
New York
$83.2K +$39.6K +12,317 +87%
T. Rowe Price Associates
24
T. Rowe Price Associates
Maryland
$72K
1CM
25
1492 Capital Management
Wisconsin
$68.5K